Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/1999
03/16/1999CA2073226C Pyrazolopyrimidinone antianginal agents
03/11/1999WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999WO1999011666A1 N-terminal modifications of rantes and methods of use
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011629A1 Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists
03/11/1999WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999WO1999011626A1 Integrin receptor antagonists
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1999011273A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011263A1 Combination therapy comprising amlodipine and a statin compound
03/11/1999WO1999011260A1 Combination therapy comprising atorvastatin and an antihypertensive agent
03/11/1999WO1999011259A1 Therapeutic combinations comprising amlodipin and atorvastatin
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999WO1998049300A3 Truncated vegf-related proteins
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999DE19738604A1 Use of Na<+>/H<+> exchange inhibitors
03/11/1999CA2304117A1 Integrin receptor antagonists
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2302350A1 Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists
03/11/1999CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999CA2302154A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
03/11/1999CA2300046A1 N-terminal modifications of rantes and methods of use
03/11/1999CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999CA2296723A1 Combination therapy comprising atorvastatin and an antihypertensive agent
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900221A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
03/10/1999EP0900219A1 Heterocyclic compounds
03/10/1999EP0900218A1 Heterocyclic compounds
03/10/1999EP0900217A1 Heterocyclic compounds
03/10/1999EP0900204A1 Heterocyclic compounds
03/10/1999EP0900202A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
03/10/1999EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0900081A1 Inhibitors of farnesyl-protein transferase
03/10/1999EP0900080A1 Novel indole and benzothiazole derivatives
03/10/1999EP0722438B1 Hydroxamic acid derivatives as inhibitors of cytokine production
03/10/1999EP0677039B1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
03/10/1999EP0649425B1 Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
03/10/1999CN1210538A Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
03/10/1999CN1210468A Pharmaceutical composition containing nitric oxide
03/10/1999CN1210461A Traitement and prevention of adverse effects of reactive oxygen species
03/10/1999CN1210013A Products and preparation of Qingqiutesu
03/10/1999CN1210008A Application of tea pigments in preparation of medicine for cor pulmonale
03/10/1999CN1209996A Medicinal composition containing ginsenoside Re, preparation and usage thereof
03/10/1999CN1209995A The use of inhibitors of sodium-hydrogen exchanger for production of medicaement for decreaing undesired effects of substances on heart
03/09/1999US5880284 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/09/1999US5880156 Antiarrhythmia agents
03/09/1999US5880155 Treatment of cardiovascular disorders
03/09/1999US5880151 Treating or preventing disease characterized by high levels of low density lipoprotein particles or cholesterol in blood
03/09/1999US5880148 Treating diabetes, arterial hypertension, restenosis and atheromatous diseases
03/09/1999US5880147 Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880124 For treatment of hypotension
03/09/1999US5880119 Angiotensin converting enzyme inhibitors; analgesics, hypotensive agents, diuretics; treating congestive heart failure, irritable bowel syndrome
03/09/1999US5880095 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/09/1999US5878750 Method of treating the syndrome of coronary heart disease risk factors in humans
03/09/1999CA2002761C Adhesive tape preparation of clonidine
03/04/1999WO1999010480A2 New tissue-specific calpaines, their production and their use
03/04/1999WO1999010371A2 Cyclopeptide derivatives as adhesion inhibitors
03/04/1999WO1999010344A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
03/04/1999WO1999010338A2 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
03/04/1999WO1999010330A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010322A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999010308A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999WO1999009985A1 Inhibitors of prenyl-protein transferase
03/04/1999WO1999009983A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999WO1998055506A3 Thrombin-inhibiting peptide
03/04/1999WO1998055074A3 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
03/04/1999WO1998054211A3 Cyclodepsipeptides and pharmaceutical compositions containing them
03/04/1999DE19737105A1 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung New tissue-specific calpain, their preparation and use
03/04/1999CA2302293A1 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999CA2301821A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999CA2301815A1 New tissue-specific calpaines, their production and their use
03/04/1999CA2301770A1 Inhibitors of prenyl-protein transferase
03/04/1999CA2301750A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
03/04/1999CA2301549A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999CA2301182A1 Cyclopeptide derivatives
03/04/1999CA2246633A1 The use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substances on the heart
03/03/1999EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS)
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899329A2 DextranaseB gene from Streptococcus pneumoniae
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
1 ... 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 ... 1595